News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
Redcare Pharmacy N.V. achieved record growth with 49% increase in sales and 3.7pp rise in adj. EBITDA margin in 2023. Full-year guidance met. Details on continued growth and positive margins for 2024 outlined by CEO Olaf Heinrich -
-
-
-